These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 12821538)

  • 1. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy.
    Sennlaub F; Valamanesh F; Vazquez-Tello A; El-Asrar AM; Checchin D; Brault S; Gobeil F; Beauchamp MH; Mwaikambo B; Courtois Y; Geboes K; Varma DR; Lachapelle P; Ong H; Behar-Cohen F; Chemtob S
    Circulation; 2003 Jul; 108(2):198-204. PubMed ID: 12821538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
    Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
    Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
    Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
    Mohammed SI; Bennett PF; Craig BA; Glickman NW; Mutsaers AJ; Snyder PW; Widmer WR; DeGortari AE; Bonney PL; Knapp DW
    Cancer Res; 2002 Jan; 62(2):356-8. PubMed ID: 11809678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
    Saishin Y; Saishin Y; Takahashi K; Melia M; Vinores SA; Campochiaro PA
    J Cell Physiol; 2003 May; 195(2):210-9. PubMed ID: 12652648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
    Olaso E; Salado C; Egilegor E; Gutierrez V; Santisteban A; Sancho-Bru P; Friedman SL; Vidal-Vanaclocha F
    Hepatology; 2003 Mar; 37(3):674-85. PubMed ID: 12601365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.
    Gupta RA; Tejada LV; Tong BJ; Das SK; Morrow JD; Dey SK; DuBois RN
    Cancer Res; 2003 Mar; 63(5):906-11. PubMed ID: 12615701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.
    Sonoshita M; Takaku K; Sasaki N; Sugimoto Y; Ushikubi F; Narumiya S; Oshima M; Taketo MM
    Nat Med; 2001 Sep; 7(9):1048-51. PubMed ID: 11533709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
    J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling.
    Gray T; Nettesheim P; Loftin C; Koo JS; Bonner J; Peddada S; Langenbach R
    Mol Pharmacol; 2004 Aug; 66(2):337-46. PubMed ID: 15266025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction.
    Tsuchida A; Nagakawa Y; Kasuya K; Itoi T; Endo M; Ozawa T; Aoki T; Koyanagi Y
    Oncol Rep; 2003; 10(2):339-43. PubMed ID: 12579269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors.
    Aoki T; Nagakawa Y; Tsuchida A; Kasuya K; Kitamura K; Inoue K; Ozawa T; Koyanagi Y; Itoi T
    Oncol Rep; 2002; 9(4):761-5. PubMed ID: 12066205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
    Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
    Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.